申请人:GIOVANNINI Riccardo
公开号:US20110082137A1
公开(公告)日:2011-04-07
The invention relates to novel 1,6-disubstituted pyrazolopyrimidinones of formula (I),
in which Hc is a tetrahydropyranyl-group and R
1
is the group V—W−*, whereby V and W independently of each other may be an aryl group or an heteroaryl group, which independently of each other may optionally be substituted.
According to one aspect of the invention the new compounds are for use as medicaments or for the manufacture of medicaments, in particular medicaments for the treatment of conditions concerning deficits in perception, concentration, learning or memory. The new compounds are also for the manufacture of medicaments and/or for use in the treatment of e.g. Alzheimer's disease, in particular for cognitive impairment associated with Alzheimer's disease.
本发明涉及一种新型的1,6-二取代吡唑嘧啶酮化合物,其化学式为(I),其中Hc为四氢吡喃基团,R1为V-W−*基团,其中V和W各自独立地可以是芳基基团或杂环基团,可以选择地进行取代。根据本发明的一个方面,这些新化合物可用作药物或制药用途,特别是用于治疗与感知、注意力、学习或记忆缺陷有关的疾病。这些新化合物还可用于制药或用于治疗例如阿尔茨海默病等疾病,特别是用于与阿尔茨海默病相关的认知障碍的治疗。